Anteo Signs Licensing Agreement

13th March 2012 Companys Announcement Office ASX Limited Exchange Centre 20 Bridge Street Sydney NSW 2000 Anteo signs licensing agreement with leading Life Science Company Agreement for the licensing of MixampGo technology with eBioscience Licensing arrangement for all global markets eBioscience operates in 70 countries and a recognised leader in Life Science reagents Agreement moves MixampGo up value chain to test manufacturers Healthy pipeline of potential commercial agreements 13 March 2012: Anteo Diagnostics Limited (ASX: ADO) is pleased to announce that it has signed a Patent and Technology License Agreement with eBioscience, a leading US headquartered Life Sciences company, providing them with access to Anteos unique MixampGo technology. Anteo Diagnostics has issued similar announcements 11 times before, most recently about 0 minutes ago on Tuesday 06 March 2012. The announcement 'Anteo Signs Licensing Agreement' was issued to the ASX on Tuesday 13 March 2012. Notice Type: Mergers, acquisitions, takeovers